CareFusion Reaches Agreement In Principle On Previously Disclosed Matter With Federal Government

CareFusion Reaches Agreement In Principle On Previously Disclosed Matter With
                              Federal Government

PR Newswire

SAN DIEGO, April 25, 2013

SAN DIEGO, April 25, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a
leading, global medical technology company,today announced an agreement in
principle to resolve previously disclosed government investigations related to
prior sales and marketing practices for its ChloraPrep® skin preparation
product and its relationships with health care professionals.

The company expects to pay the government approximately $41 million to resolve
the allegations. CareFusion will record the charge in the third quarter of
fiscal 2013 to establish a reserve for this amount. In connection with these
matters, CareFusion has entered into a non-prosecution agreement and will
continue to cooperate with the government.

"We are pleased to have reached this important milestone as we continue to
build our foundation for future growth," said Kieran T. Gallahue, chairman and
CEO. "Since our spinoff, we have made significant investments to improve our
quality systems, including our sales and marketing practices, and we remain
committed to adhering to the highest standards."

The agreement in principle remains subject to several conditions, including
the completion and execution of a formal settlement agreement and other
required documentation. The amount and timing of the payment are subject to
the final terms of the settlement agreement.

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care
industry with products and services that help hospitals measurably improve the
safety and quality of care. The company develops market-leading technologies
including Alaris® infusion pumps, Pyxis® automated dispensing and patient
identification systems, AVEA®, AirLife™ and LTV® series ventilation and
respiratory products, ChloraPrep® products, MedMined® services for data mining
surveillance, V. Mueller® surgical instruments, and an extensive line of
products that support interventional medicine. CareFusion employs more than
15,000 people across its global operations. More information may be found at

Cautions Concerning Forward-looking Statements

The CareFusion news release and the information contained herein present
"forward-looking statements" addressing expectations, prospects, estimates and
other matters that are dependent upon future events or developments.
Forward-looking statements include, but are not limited to, statements
regarding the agreement in principle with the government, including the
proposed settlement terms, the timing of the settlement agreement and the
payment amount. CareFusion intends forward-looking terminology such as
"believes," "expects," "may," "will," "should," "anticipates," "plans," or
similar expressions to identify forward-looking statements. Such statements
are subject to certain risks and uncertainties, which could cause the
company's actual results to differ materially from those anticipated by the
forward-looking statements. These risks and uncertainties include, but are not
limited to, the company and the government may not complete the required
documentation or finalize the settlement on the proposed terms or timing, or
at all, as well as other risks described more fully in Item 1A in the
company's Annual Report on Form 10-K for the fiscal year ended June 30, 2012,
which are expressly incorporated herein by reference, and other factors as may
periodically be described in the company's filings with the SEC. The
CareFusion news release and the information contained herein reflect
management's views as of April 25, 2013. Except to the limited extent required
by applicable law, CareFusion undertakes no obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.

SOURCE CareFusion Corp.

Contact: Media, Kristen Cardillo, (858) 617-2317,, or Investors, Jim Mazzola, (858) 617-1203,
Press spacebar to pause and continue. Press esc to stop.